title: Left ventricular diastolic function in patients with treated haemochromatosis.
abstract: OBJECTIVE
  We recently demonstrated reduced exercise capacity in phlebotomy treated genetic haemochromatosis in spite of normal systolic function. The present objective was to investigate diastolic function at rest.
  
  
  METHODS
  Diastolic function was echocardiographically assessed in 132 phlebotomy treated genetic haemochromatosis patients and 50 controls.
  
  
  RESULTS
  Patients had higher body mass index and heart rate, higher transmitral early (E) (11.2+/-2.6 versus 10.4+/-2.2 cm) and atrial (A) (5.7+/-1.6 versus 5.0+/-1.6) velocity time integrals, pulmonary venous systolic peak velocity (0.58+/-0.12 versus 0.54+/-0.13 m/s) and ratio of E to spectral tissue Doppler E' velocity (6.3+/-1.6 versus 5.6+/-1.4, all p <0.05). Independently of age, heart rate, systolic blood pressure and body weight, having haemochromatosis remained statistically significantly associated with higher E (beta=0.27) and A (beta =0.18) velocity time integrals, pulmonary venous systolic peak velocity (beta =0.21), and E/E'-ratio (beta=0.25) in separate multivariate analyses (all p <0.05). In the youngest age tertile, patients had longer isovolumic relaxation time and lower E' than controls.
  
  
  CONCLUSIONS
  Our findings are compatible with mildly impaired diastolic function in treated haemochromatosis, with delayed relaxation in the younger tertile, and an elevated filling pressure and pseudonormalisation with increasing age.
authors.affiliation: Department of Heart Disease, Haukeland University Hospital, Norway. einar.davidsen@helse-bergen.no
authors.forename: Einar Skulstad
authors.initials: ES
authors.lastname: Davidsen
authors.forename: Per
authors.initials: P
authors.lastname: Omvik
authors.forename: Tor
authors.initials: T
authors.lastname: Hervig
authors.forename: Eva
authors.initials: E
authors.lastname: Gerdts
mesh_terms: D000328:Adult; D017677:Age Distribution; D000367:Age Factors; D001794:Blood Pressure; D001835:Body Weight; D016022:Case-Control Studies; D003971:Diastole; D015150:Echocardiography, Doppler; D005260:Female; D006339:Heart Rate; D006432:Hemochromatosis / Q000000981:diagnostic imaging / Q000235:genetics / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009200:Myocardial Contraction; D018962:Phlebotomy; D016896:Treatment Outcome; D016277:Ventricular Function, Left